secwatch.observer — SEC 8-K summary
======================================

Issuer:     Elevance Health, Inc. (ELV)
CIK:        0001156039
Form:       8-K
Filed at:   2025-03-10T23:59:59+00:00
Accession:  0001193125-25-050889
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Elevance Health reaffirms FY 2025 adjusted EPS guidance of $34.15-$34.85
------------------------------------------------------------------------

- Reaffirms 2025 shareholders' earnings per diluted share of $30.40-$31.10, including ~$3.75 net unfavorable items.
- Adjusted shareholders' earnings guidance unchanged at $34.15-$34.85 per diluted share.
- Expects 2025 year-end total medical enrollment consistent with prior guidance; Medicare Advantage members 2.2-2.25 million.
- Management to reiterate these projections in investor meetings over coming weeks.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1156039/000119312525050889/0001193125-25-050889-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1156039/000119312525050889/d926071d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-050889

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer